A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The primary objective of this early-stage clinical study is to demonstrate an effect of single doses of CK-2017357 on measures of skeletal muscle function and fatigability in patients with peripheral artery disease and symptomatic claudication.
Epistemonikos ID: d4b4cfdb05d4073e55f9eef64d5b910f7877331d
First added on: May 05, 2024